Study of inflammatory biomarkers which may aid in early detection of ventilator-associated pneumonia (VAP) in children and predicting their outcome.
Patients:
Thirty-five children, aged 2 months to 13 years, needed mechanical ventilation (MV) for more than 48 hours due to causes other than pneumonia.
Methods:
Measurement of serum amyloid A (SAA) protein, soluble intercellular adhesion molecule 1 (sICAM-1), and C-reactive protein (CRP), modified clinical pulmonary infection score (CPIS) and performing culture of endotracheal aspirate at the start and on the third day of MV.
Results:
Ventilator-associated pneumonia was diagnosed by CPIS in 6 (17.1%) of 35 patients. On the third day of MV, there was a significant increase in serum mean levels of SAA, sICAM-1, and CRP in comparison to the start of MV (P = .005, .004, and .01, respectively). Three (50%) of 6 patients with VAP died, while 4 (14.28%) of 28 patients without VAP died. The sensitivity of serum SAA, sICAM-1, and CPIS were 100% for predicting VAP, while specificity was highest for CPIS (96.55%) followed by SAA (93.1%). Combination of CPIS and SAA increased the specificity to 100%. For predicting nonsurvival, serum SAA and sICAM-1 had a sensitivity of 100% and a specificity of 92.86% and 89.29%, respectively.
Conclusion:
Serum amyloid A and sICAM-1 may be considered as reliable markers for detection of VAP. Combination of serum SAA with CPIS increased the specificity to 100%. Measurement of SAA in patients with VAP also had a good predictive value for nonsurvival in such patients.
GadaniHVyasAKarAK. A study of ventilator-associated pneumonia: incidence, outcome, risk factors and measures to be taken for prevention. Indian J Anaesth. 2010;54(6):535–540.
2.
ChoudhuriAH.Ventilator-associated pneumonia: when to hold the breath?Int J Crit Illn Inj Sci. 2013;3(3):169–174.
3.
GuillametCVKollefMH. Ventilator associated pneumonia in the ICU: where has it gone?. Curr Opin Pulm Med. 2015;21(3):226–231.
4.
NairSSenNPeterJVRajJPBrahmadathanKN. Role of quantitative endotracheal aspirate and cultures as a surveillance and diagnostic tool for ventilator- associated pneumonia: a pilot study. Indian J Med Sci. 2008;62(8):304–313.
5.
RosboltMBSterlingESFahyBG.The utility of the clinical pulmonary infection score. J Intensive Care Med2009;24(1):26–34.
6.
EklundKKNiemiKKovanenPT.Immune functions of serum amyloid A. Crit Rev Immunol. 2012;32(4):335–348.
7.
CowleyHCHeneyDGearingAJHemingwayIWebsterNR.Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Crit Care Med. 1994;22(4):651–656.
8.
PelosiPBarassiASevergniniP. Prognostic role of clinical and laboratory criteria to identify early ventilator-associated pneumonia in brain injury. Chest. 2008;134(1):101–108.
9.
FroonAHBontenMJGaillardCA. Prediction of clinical severity and outcome of ventilator-associated pneumonia. Comparison of simplified acute physiology score with systemic inflammatory mediators. Am J Respir Crit. Care Med. 1998;158(4):1026–1031.
10.
da SilvaPSde AguiarVEde CarvalhoWBMachado FonsecaMC. Value of clinical pulmonary infection score in critically ill children as a surrogate for diagnosis of ventilator-associated pneumonia. J Crit Care. 2014;29(4):545–550.
11.
CirulisMMHameleMTStockmannCRBennettTDBrattonSL. Comparison of the new adult ventilator-associated event criteria to the centers for disease control and prevention pediatric ventilator-associated pneumonia definition (PNU2) in a population of pediatric traumatic brain injury patients. Pediatr Crit Care Med. 2016;17(2):157–164.
12.
WalkeyAJReardonCCSulisCANaceRNJoyce-BradyM. Epidemiology of ventilator-associated pneumonia in a long-term acute care hospital. Infect Control Hosp Epidemiol. 2009;30(4):319–324.
13.
SönmezDüzkayaDYildizS. Effect of two different feeding methods on preventing ventilator associated pneumonia in the paediatric intensive care unit (PICU): a randomised controlled study. Aust Crit Care. 2016;29(3):139–145.
14.
CroceMASwansonJMMagnottiLJ. The futility of the clinical pulmonary infection score in trauma patients. J Trauma. 2006;60(3):523–527.
15.
PóvoaPMartin-LoechesIRamirezP. Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAPstudy. Ann Intensive Care. 2016;6(1):32.
16.
IosifidisEStabouliSTsolakiA. Diagnosing ventilator-associated pneumonia in pediatric intensive care. Am J Infect Control. 2015;43(4):390–393.
17.
CohenMJBirNRahnP. Protein C depletion early after trauma increases the risk of ventilator-associated pneumonia. J Trauma. 2009;67(6):1176–1181.
18.
KaraoglanHYalcinANCengizM. Cost analysis of ventilator-associated pneumonia in Turkish medical-surgical intensive care units. Infez Med. 2010;18(4):248–255.
19.
ZhouCDLuZYRenNZZhangGC. Diagnostic value of procalcitonin in ventilator-associated pneumonia [in Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006;18(6):370–372.
20.
LinssenCFBekersODrentMJacobsJA. C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem. 2008;45(pt 3):293–298.
21.
RenckensRRoelofsJJKnappSde VosAFFlorquinSvan der PollT. The acute-phase response and serum amyloid A inhibit the inflammatory response to Acinetobacter baumannii pneumonia. J Infect Dis. 2006;15;193(2):187–195.
22.
LiuCYJinPYangYX. Relationship between soluble intercellular adhesion molecule-1 and severe pneumonia [in Chinese]. Zhongguo Dang Dai Er Ke Za Zhi. 2007;9(6):537–539.
23.
DehouxMSBouttenAOstinelliJ. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med. 1994;150(3):710–716.
24.
YangGHWangGF. Value of the clinical pulmonary infection score for the prognosis of ventilator-associated pneumonia [in Chinese]. Zhonghua Jie He He Hu Xi ZaZhi. 2006;29(11):751–754.
25.
JungBEmbriacoNRouxF. Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score. Intensive Care Med. 2010;36(5):790–798.
26.
LunaCMBlanzacoDNiedermanMSResolution of ventilator-associated pneumonia: prospective evaluation of the clinical infection scores as an early clinical predictor of outcome. Crit Care Med. 2003;31(3):676-682.
27.
LuytCEChastreJFagonJY.Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med. 2004;30(5):844–852.
28.
VeinsteinABrun-BuissonCDerrodeNValidation of an algorithm based on direct examination of specimens in suspected ventilator-associated pneumonia. Intensive Care Med. 2006;32(5):676-683.
29.
SeligmanRMeisnerMLisboaTC. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care. 2006;10(5):R125.
30.
LiaoXLJinXDKangY. Role of procalcitonin in the diagnosis of ventilator-associated pneumonia [in Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010;22(3):142–145.
31.
VernikosPKampolisCFKonstantopoulosKArmaganidisAKarakitsosP. The Role of bronchoscopic findings and bronchoalveolar lavage fluid cytology in early diagnosis of ventilator-associated pneumonia. Respir Care. 2016;61(5):658–667.
32.
HillasGVassilakopoulosTPlantzaPRasidakisABakakosP. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia. Eur Respir J. 2010;35(4):805–811.
33.
ZilberbergMDShorrAF. Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clin Infect Dis. 2010;51(
suppl 1
):S131–S135.
34.
ZhouXYBenSQChenHLNiSS. A comparison of APACHE II and CPIS scores for the prediction of 30-day mortality in patients with ventilator-associated pneumonia. Int J Infect Dis. 2015;30:144–147.
